MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/heartjnl-2016-310450

Медицинская библиотека · Heart (British Cardiac Society) · 2017

Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.

Bielinski Suzette J, Berardi Cecilia, Decker Paul A, Larson Nicholas B, Bell Elizabeth J, Pankow James S, Sale Michele M, Tang Weihong, Hanson Naomi Q, Wassel Christina L, de Andrade Mariza, Budoff Matthew J, Polak Joseph F, Sicotte Hugues, Tsai Michael Y

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

OBJECTIVE

To determine if hepatocyte growth factor (HGF), a promising biomarker of coronary heart disease (CHD) given its release into circulation in response to endothelial damage, is associated with subclinical and clinical CHD in a racial/ethnic diverse population.

METHODS

HGF was measured in 6738 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Highest mean HGF values (pg/mL) were observed in Hispanic, followed by African, non-Hispanic white, then Chinese Americans.

RESULTS

In all races/ethnicities, HGF levels were associated with older age, higher systolic blood pressure (SBP) and body mass index, lower high-density lipoprotein, diabetes and current smoking. In fully adjusted models, each SD higher HGF was associated with an average increase in coronary artery calcium (CAC) of 55 Agatston units for non-Hispanic whites (p<0.001) and 51 Agatston units for African-Americans (p=0.007) but was not in the other race/ethnic groups (interaction p=0.02). There were 529 incident CHD events, and CHD risk was 41% higher in African (p<0.001), 17% in non-Hispanic white (p=0.026) and Chinese (p=0.36), and 6% in Hispanic Americans (p=0.56) per SD increase in HGF.

CONCLUSION

In a large and diverse population-based cohort, we report that HGF is associated with subclinical and incident CHD. We demonstrate evidence of racial/ethnic heterogeneity within these associations, as the results are most compelling in African-Americans and non-Hispanic white Americans. We provide evidence that HGF is a biomarker of atherosclerotic disease that is independent of traditional risk factors.

Для цитирования: Bielinski Suzette J, Berardi Cecilia, Decker Paul A, Larson Nicholas B, Bell Elizabeth J, Pankow James S, Sale Michele M, Tang Weihong, Hanson Naomi Q, Wassel Christina L, de Andrade Mariza, Budoff Matthew J, Polak Joseph F, Sicotte Hugues, Tsai Michael Y. Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease.. Heart (British Cardiac Society). 2017. DOI: 10.1136/heartjnl-2016-310450.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.